Article
Lasp1 is down-regulated in NMDA receptor antagonist-treated mice and implicated in human schizophrenia susceptibility.
Journal of psychiatric research - 1 Jan 2013
Joo Jaesoon, Lee Soojeong, Nah Seong-Su, Kim Young Ock, Kim Duk-Soo, Shim Se-Hoon, Hwangbo Young, Kim Hyung-Kee, Kwon Jun-Tack, Kim Jong Woo, Song Ho-Yeon, Kim Hak-Jae
Abstract excerpt
Mice treated with MK-801, a non-competitive antagonist of the N-methyl-d-aspartic (NMDA) acid receptor, are important animal models for schizophrenia studies. In the present study, we compared protein expression levels in the hippocampus of mice treated with MK-801 (0.6 mg/kg) or saline once daily for 7 days. Changes in the proteome were detected by two-dimensional electrophoresis, and the six proteins exhibiting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
